{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:43:11Z","timestamp":1783003391704,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s11914-005-0016-8","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T14:10:28Z","timestamp":1180707028000},"page":"92-97","source":"Crossref","is-referenced-by-count":17,"title":["Role of the immune system in postmenopausal bone loss"],"prefix":"10.1007","volume":"3","author":[{"given":"M. Neale","family":"Weitzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","volume":"88","author":"R Pacifici","year":"1991","unstructured":"Pacifici R, Brown C, Puscheck E, et al.: Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 1991, 88:5134\u20135138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","volume":"94","author":"R Kitazawa","year":"1994","unstructured":"Kitazawa R, Kimble RB, Vannice JL, et al.: Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994, 94:2397\u20132406.","journal-title":"J Clin Invest"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/endo.136.7.7789332","volume":"136","author":"RB Kimble","year":"1995","unstructured":"Kimble RB, Matayoshi AB, Vannice JL, et al.: Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 1995, 136:3054\u20133061.","journal-title":"Endocrinology"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI119333","volume":"99","author":"P Ammann","year":"1997","unstructured":"Ammann P, Rizzoli R, Bonjour JP, et al.: Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1997, 99:1699\u20131703.","journal-title":"J Clin Invest"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C, et al.: Estrogen deficiency induces bone loss by enhancing T-cell production of TNFalpha. J Clin Invest 2000, 106:1229\u20131237. This study demonstrated for the first time that ovariectomy induced bone loss in an animal model of postmenopausal osteoporosis is driven by TNF\u00e0 derived from T cells.","journal-title":"J Clin Invest"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, et al.: TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000, 106:1481\u20131488.","journal-title":"J Clin Invest"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","volume":"276","author":"YH Zhang","year":"2001","unstructured":"Zhang YH, Heulsmann A, Tondravi MM, et al.: Tumor Necrosis Factor-alpha (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways. J Biol Chem 2001, 276:563\u2013568.","journal-title":"J Biol Chem"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.0136772100","volume":"100","author":"G Toraldo","year":"2003","unstructured":"Toraldo G, Roggia C, Qian WP, et al.: IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci U S A 2003, 100:125\u2013130. This study demonstrated for the first time that IL-7 induces bone destruction in vivo by a mechanism involving T cells.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","volume":"143","author":"K Fuller","year":"2002","unstructured":"Fuller K, Murphy C, Kirstein B, et al.: TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002, 143:1108\u20131118.","journal-title":"Endocrinology"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR, et al.: Interleukin-1b and tumor necrosis factor-\u00e0, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999, 25:255\u2013259.","journal-title":"Bone"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"E1011","DOI":"10.1152\/ajpendo.00534.2004","volume":"288","author":"LC Gilbert","year":"2005","unstructured":"Gilbert LC, Rubin J, Nanes MS: The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independent of apoptosis. Am J Physiol Endocrinol Metab 2005, 288:E1011-E1018.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","volume":"98","author":"C Roggia","year":"2001","unstructured":"Roggia C, Gao Y, Cenci S, et al.: Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 2001, 98:13960\u201313965. This study demonstrated definitively that TNF\u00e0 production by T cells was central to ovariectomy induced bone loss in mice by transplanting T cells from wild type and TNF\u00e0 null mice into nude mice.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.1073\/pnas.94.17.9360","volume":"94","author":"C Miyaura","year":"1997","unstructured":"Miyaura C, Onoe Y, Inada M, et al.: Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci U S A 1997, 94:9360\u20139365.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood.V96.5.1873","volume":"96","author":"MN Weitzmann","year":"2000","unstructured":"Weitzmann MN, Cenci S, Rifas L, et al.: Interleukin-7 stimulates osteoclast formation by up-regulating the T- cell production of soluble osteoclastogenic cytokines. Blood 2000, 96:1873\u20131878.","journal-title":"Blood"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","volume":"110","author":"MN Weitzmann","year":"2002","unstructured":"Weitzmann MN, Roggia C, Toraldo G, et al.: Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002, 110:1643\u20131650. This study demonstrated for the first time that IL-7 was a critical component of ovariectomy induced bone loss in mice. The study shows that in vivo neutralization of IL-7 by antibody prevented bone loss after ovariectomy.","journal-title":"J Clin Invest"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/en.2002-221057","volume":"144","author":"SK Lee","year":"2003","unstructured":"Lee SK, Kalinowski JF, Jastrzebski SL, et al.: Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 2003, 144:3524\u20133531.","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"16_CR17","first-page":"S31","volume":"19","author":"M Ryan","year":"2004","unstructured":"Ryan M, Grassi F, Qian W-P, et al.: Estrogen represses hematopoietic stem cell proliferation, thymopoiesis, thymic output, and T cell peripheral expansion through IL-7. Proceedings of the Twenty Sixth Annual Meeting of the American Society for Bone and Mineral Research. 2004, Seattle. J Bone Miner Res 2004, 19(Suppl 1):S31.","journal-title":"J Bone Miner Res"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0531-5565(01)00213-3","volume":"37","author":"D Andrew","year":"2002","unstructured":"Andrew D, Aspinall R: Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002, 37:455\u2013463.","journal-title":"Exp Gerontol"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.166.3.1524","volume":"166","author":"D Andrew","year":"2001","unstructured":"Andrew D: Aspinall R Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 2001, 166:1524\u20131530.","journal-title":"J Immunol"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0264-410X(99)00499-5","volume":"18","author":"DC Douek","year":"2000","unstructured":"Douek DC, Koup RA: Evidence for thymic function in the elderly. Vaccine 2000, 18:1638\u20131641.","journal-title":"Vaccine"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","volume":"13","author":"BL Riggs","year":"1998","unstructured":"Riggs BL, Khosla S, Melton LJ, 3rd: A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998, 13:763\u2013773.","journal-title":"J Bone Miner Res"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1471-4906(01)02028-2","volume":"22","author":"TJ Fry","year":"2001","unstructured":"Fry TJ, Mackall CL: Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001, 22:564\u2013571.","journal-title":"Trends Immunol"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ard.62.2.113","volume":"62","author":"JA Roon van","year":"2003","unstructured":"van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP: Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:113\u2013119. This study demonstrated elevated levels of IL-7 in the serum of RA patients and makes important links between IL-7 and CD4+ synovial T cell production of IFN\u00e3 and TNF\u00e0 in RA.","journal-title":"Ann Rheum Dis"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/emboj\/16.10.2851","volume":"16","author":"A Muhlethaler-Mottet","year":"1997","unstructured":"Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B: Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. Embo J 1997, 16:2851\u20132860.","journal-title":"Embo J"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.1533207100","volume":"100","author":"S Cenci","year":"2003","unstructured":"Cenci S, Toraldo G, Weitzmann MN, et al.: Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A 2003, 100:10405\u201310410. This study demonstrated for the first time that antigen presentation by macrophages is critical to the bone loss induced by ovariectomy in mice.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","volume":"332","author":"LL Key Jr.","year":"1995","unstructured":"Key LL, Jr., Rodriguiz RM, Willi SM, et al.: Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995, 332:1594\u20131599.","journal-title":"N Engl J Med"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, et al.: T-cell-mediated regulation of osteoclastogenesis by signalling cross- talk between RANKL and IFN-gamma. Nature 2000, 408:600\u2013605.","journal-title":"Nature"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar612","volume":"5","author":"W Huang","year":"2003","unstructured":"Huang W, O\u2019Keefe RJ, Schwarz EM: Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther 2003, 5:R49-R59.","journal-title":"Arthritis Res Ther"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","volume":"2","author":"DE Hughes","year":"1996","unstructured":"Hughes DE, Dai A, Tiffee JC, et al.: Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996, 2:1132\u20131136.","journal-title":"Nat Med"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N","volume":"78","author":"MN Weitzmann","year":"2000","unstructured":"Weitzmann MN, Cenci S, Haug J, et al.: B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem 2000, 78:318\u2013324.","journal-title":"J Cell Biochem"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1073\/pnas.0404888101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao Y, Qian WP, Dark K, et al.: Estrogen prevents bone loss through transforming growth factor \u00e2 signaling in T cells. Proc Natl Acad Sci U S A 2004, 101:16618\u201316623. This study demonstrated that TGF\u00e2 signaling in T cells is a critical mechanism by which estrogen protects bone mass.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.159.1.117","volume":"159","author":"J Tang","year":"1997","unstructured":"Tang J, Nuccie BL, Ritterman I, et al.: TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997, 159:117\u2013125.","journal-title":"J Immunol"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jnci\/87.8.593","volume":"87","author":"SM Dubinett","year":"1995","unstructured":"Dubinett SM, Huang M, Dhanani S, et al.: Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7. J Natl Cancer Inst 1995, 87:593\u2013597.","journal-title":"J Natl Cancer Inst"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.163.5.1037","volume":"163","author":"JH Kehrl","year":"1986","unstructured":"Kehrl JH, Wakefield LM, Roberts AB, et al.: Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986, 163:1037\u20131050.","journal-title":"J Exp Med"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.4049\/jimmunol.158.5.2065","volume":"158","author":"YJ Lee","year":"1997","unstructured":"Lee YJ, Han Y, Lu HT, et al.: TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol 1997, 158:2065\u20132075.","journal-title":"J Immunol"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1172\/JCI117187","volume":"93","author":"RB Kimble","year":"1994","unstructured":"Kimble RB, Vannice JL, Bloedow DC, et al.: Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994, 93:1959\u20131967.","journal-title":"J Clin Invest"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, et al.: IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005, 115:282\u2013290.","journal-title":"J Clin Invest"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1073\/pnas.93.20.10785","volume":"93","author":"A Matayoshi","year":"1996","unstructured":"Matayoshi A, Brown C, DiPersio JF, et al.: Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci U S A 1996, 93:10785\u201310790.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, et al.: Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003, 111:1221\u20131230.","journal-title":"J Clin Invest"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(96)00384-5","volume":"20","author":"B Abrahamsen","year":"1997","unstructured":"Abrahamsen B, Bendtzen K, Beck-Nielsen H: Cytokines and Tlymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL- 1 or IL-1ra. Bone 1997, 20:251\u2013258.","journal-title":"Bone"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","volume":"2","author":"CC Whitacre","year":"2001","unstructured":"Whitacre CC: Sex differences in autoimmune disease. Nat Immunol 2001, 2:777\u2013780.","journal-title":"Nat Immunol"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/07853899709007474","volume":"29","author":"P Isomaki","year":"1997","unstructured":"Isomaki P, Punnonen J: Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med 1997, 29:499\u2013507.","journal-title":"Ann Med"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","volume":"85","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini R: Rheumatoid arthritis. Cell 1996, 85:307\u2013310.","journal-title":"Cell"},{"key":"16_CR44","first-page":"1920","volume":"17","author":"S Goemaere","year":"1990","unstructured":"Goemaere S, Ackerman C, Goethals K: Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990, 17:1920\u20131922.","journal-title":"J Rheumatol"},{"key":"16_CR45","first-page":"10","volume":"44","author":"RL Wilder","year":"1996","unstructured":"Wilder RL: Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol 1996, 44(Suppl):10\u201312.","journal-title":"J Rheumatol"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3949\/ccjm.61.4.276","volume":"61","author":"RF Vollenhoven Van","year":"1994","unstructured":"Van Vollenhoven RF, McGuire JL: Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleve Clin J Med 1994, 61:276\u2013284.","journal-title":"Cleve Clin J Med"},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/art.1780371014","volume":"37","author":"GM Hall","year":"1994","unstructured":"Hall GM, Daniels M, Doyle DV, Spector TD: Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994, 37:1499\u20131505.","journal-title":"Arthritis Rheum"},{"key":"16_CR48","first-page":"1581","volume":"22","author":"F Benedetti De","year":"1995","unstructured":"De Benedetti F, Massa M, Pignatti P, et al.: Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol 1995, 22:1581\u20131585.","journal-title":"J Rheumatol"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L","volume":"42","author":"S Harada","year":"1999","unstructured":"Harada S, Yamamura M, Okamoto H, et al.: Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:1508\u20131516.","journal-title":"Arthritis Rheum"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, et al.: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304\u2013309. While T cells have long been associated with inflammation in RA this landmark study demonstrated that the bone destruction in an animal model of RA was also a consequence of T cell derived osteoclastogenic cytokines, in particular RANKL.","journal-title":"Nature"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-005-0016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-005-0016-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-005-0016-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:06:16Z","timestamp":1683864376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-005-0016-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s11914-005-0016-8","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}